How to Finance a Medical Billing Company Acquisition

From SBA 7(a) loans to earnout structures, understand the capital stack options for acquiring a profitable RCM business in the $1M–$5M revenue range.

Find Medical Billing Company Deals SBA Calculator →

Medical billing companies are among the most financeable lower middle market businesses due to their recurring contract revenue, recession-resistant demand, and strong EBITDA margins. Buyers typically combine SBA 7(a) debt, seller notes, and performance-based earnouts to acquire these businesses at 3.5–6x EBITDA, with lenders favoring diversified client bases, documented compliance histories, and certified coding staff.

Financing Options for Medical Billing Company Acquisitions

SBA 7(a) Loan

$500K–$5MPrime + 2.75%–3.5% (currently ~10.5%–11.5%)

The primary financing vehicle for individual operators acquiring medical billing companies, covering up to 90% of purchase price. Lenders value recurring RCM contracts, strong net collection rates, and clean HIPAA compliance records when underwriting.

Pros

Low down payment of 10% allows buyers to preserve capital for working capital and technology upgrades post-close
Long 10-year amortization keeps monthly debt service manageable against stable recurring billing revenue
SBA lenders familiar with service businesses will underwrite against EBITDA from recurring RCM contracts

Cons

×Full personal guarantee required, creating significant personal liability exposure for the buyer
×Lenders will heavily scrutinize client concentration risk if any single practice exceeds 25–30% of revenue
×HIPAA compliance gaps or unresolved payer audit findings can stall or kill SBA underwriting approval

Seller Note

10%–20% of purchase price6%–8% fixed, interest-only periods negotiable

Owner financing where the seller accepts a portion of the purchase price as a promissory note, typically subordinated to SBA debt. Common in medical billing deals to bridge valuation gaps and keep the seller invested during client relationship transitions.

Pros

Aligns seller incentives with a smooth post-close transition, reducing the risk of client attrition during ownership change
Reduces buyer's required equity injection when combined with SBA financing, improving acquisition ROI
Negotiable repayment terms allow structured relief during the critical first 12 months post-acquisition

Cons

×SBA rules require seller note to be on full standby for 24 months, limiting seller's near-term cash access
×Seller may push for higher purchase price in exchange for accepting deferred payment terms
×Note becomes a liability if revenue drops post-close due to client departures or coding staff turnover

Earnout Structure

15%–25% of total purchase price over 12–24 monthsNo interest; structured as contingent equity payment based on agreed KPIs

A contingent payment mechanism tying 15–25% of total purchase price to post-close performance metrics such as client retention rates and revenue thresholds. Particularly effective for medical billing deals with key-person dependency or client concentration risk.

Pros

Protects buyer from overpaying if anchor clients depart or collection rates deteriorate post-acquisition
Motivates seller to actively support client relationship transitions and staff retention during earnout period
Enables higher headline valuation offers that satisfy seller price expectations while managing buyer risk

Cons

×Earnout disputes are common if KPIs are loosely defined or client attrition attribution is ambiguous
×Seller loses control post-close while remaining financially exposed to buyer's operational decisions
×Requires robust post-close reporting infrastructure and agreed measurement methodology to avoid conflict

Sample Capital Stack

$2,800,000 (representing a 4.7x multiple on $595,000 EBITDA)

Purchase Price

~$28,500/month on SBA note at 11% over 10 years, well within cash flow from $595K EBITDA

Monthly Service

Approximately 1.74x DSCR, comfortably above the 1.25x minimum SBA lenders require for service business acquisitions

DSCR

SBA 7(a) Loan: $2,240,000 (80%) | Seller Note on Standby: $420,000 (15%) | Buyer Equity: $140,000 (5%)

Model your own deal structure →

Lender Tips for Medical Billing Company Acquisitions

1Prepare a client revenue concentration analysis before approaching lenders — SBA underwriters will flag any single medical practice representing more than 25% of total billings as a credit risk.
2Compile three years of clean CPA-prepared financials with revenue broken out by client and specialty; lenders cannot underwrite recurring revenue without documented contract-level detail.
3Document your HIPAA compliance posture upfront — signed BAAs, security risk assessments, and audit history — because compliance gaps discovered in underwriting will trigger lender re-pricing or deal abandonment.
4Identify a credible seller transition plan covering at least 90 days of post-close involvement; lenders and SBA guarantors expect key-person risk mitigation before funding owner-operated RCM businesses.

Frequently Asked Questions

Can I use an SBA 7(a) loan to buy a medical billing company?

Yes. Medical billing companies are SBA-eligible service businesses. Lenders underwrite based on recurring contract revenue, EBITDA, and client diversification. A minimum $500K EBITDA with clean financials typically supports full SBA 7(a) financing up to $5M.

How do earnouts work in a medical billing acquisition?

Earnouts tie 15–25% of the purchase price to post-close metrics like client retention rates or revenue thresholds measured over 12–24 months. They protect buyers from client attrition risk and allow sellers to achieve higher total valuations tied to business performance.

What EBITDA multiple should I expect to pay for a medical billing company?

Lower middle market medical billing companies typically trade at 3.5–6x EBITDA. Businesses with diversified specialty clients, 95%+ net collection rates, documented SOPs, and long-term contracts command multiples at the higher end of that range.

How does client concentration affect acquisition financing for an RCM business?

Client concentration is the top lender concern. If one practice represents more than 25–30% of revenue, SBA lenders may reduce loan-to-value, require larger down payments, or mandate earnout protections to guard against post-close revenue loss from client departure.

More Medical Billing Company Guides

Buy a Medical Billing Company Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Medical Billing Company acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required